December 12, 2016
Alvogen’s flu capsules alternative for Tamiflu
Alvogen on Monday launched the first flu capsules, generic equivalent to Roche’s Tamiflu (oseltamivir phosphate) capsules in the United States.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Business
December 12, 2016
Ipsen science boss, R&D Vice President Claude Bertrand leaves
French drugmaker Ipsen said on Monday that Claude Bertrand, Executive Vice President, R&D, Chief Scientific Officer, will step down in January…
December 12, 2016
Short: Sycomore Asset Management’s share of Biocartis trigers transparency act
Biocartis Group NV said on Monday, in accordance with the Belgian Transparency Act, that Sycomore Asset Management now holds 3.01% of the…
December 12, 2016
Mereo balance sheet strong, sufficient funds for clinical tests
Mereo BioPharma Group, a clinical stage, UK-based biopharmaceutical company focused on rare diseases, is looking to strengthen its rare and specialty disease…
December 12, 2016
Herantis gets funds for its Parkinson’s disease study
The research and innovation program of the European Union, Horizon 2020, has awarded a grant of approximately €6.0 million for…
December 9, 2016
Allergan dissapointed with PTAB’s reaction as Mylan petitions for IPR of Restasis patents
Allergan said on Thursday that it was disappointed in the PTAB’s decision to institute IPR proceedings regarding the patents that…
December 8, 2016
EMA to review Sanofi/Regeneron’s skin disease treatment Dupixent
Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application…
December 8, 2016
Novartis gets eye disease drug European approval
European Commission (EC) has granted an additional indication for Novartis’s Lucentis (ranibizumab) to treat patients with eye disease due to…
December 8, 2016
Erytech places shares, funds acute leukemia drug
Acute leukemia focused pharmaceutical company Erytech Pharma, has announced the closing of a private placement of 793,877 ordinary shares to…
December 8, 2016
Bristol-Myers raises its quarterly dividend
Bristol-Myers Squibb Company has declared an increase of 2.6% percent in the its quarterly dividend, beginning in the first quarter…